Literature DB >> 25273899

Hierarchical regulation of wound healing by NOD-like receptors in cardiovascular disease.

Nathan A Bracey1, Henry J Duff, Daniel A Muruve.   

Abstract

SIGNIFICANCE: Persistent nonmicrobial tissue injury leads to the nonlinear activation of integrated wound-healing pathways. In chronic cardiovascular diseases, local tissue undergoes dynamic remodeling involving both structural cells and professional innate immune cells in attempts to limit burden of injury. While the final effector mechanisms by which these different cellular populations participate in wound healing are functionally distinct, their upstream molecular signaling pathways can often be shared. RECENT ADVANCES: The NOD-like receptors (NLRs) are intracellular pattern recognition receptors that have been well characterized as key regulators of pro-inflammatory cytokine production in innate immune cells. However, recent evidence has shown that some NLR proteins are additionally expressed by resident structural cells despite negligible cytokine production. These results indicate the potential for noncanonical routes of innate immune signaling by NLRs within solid organ systems. CRITICAL ISSUES: Here, we review the emerging functions of NLR proteins in professional immune and tissue-resident cells, and discuss the implications in wound healing during chronic cardiovascular diseases. Emphasis is placed on NLRP3 and its regulation of cardiac structure and function in response to injury. Specific cellular and subcellular signaling paradigms are also discussed. FUTURE DIRECTIONS: The characterization of how NLRs participate in homeostasis during cellular injury is essential to develop their potential utility for therapeutic intervention in cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25273899     DOI: 10.1089/ars.2014.6125

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.

Authors:  Guangbi Li; Zhida Chen; Owais M Bhat; Qinghua Zhang; Justine M Abais-Battad; Sabena M Conley; Joseph K Ritter; Pin-Lan Li
Journal:  J Lipid Res       Date:  2017-04-12       Impact factor: 5.922

2.  Cardiovascular pathobiology of inflammasomes: inflammatory machinery and beyond.

Authors:  Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-04-01       Impact factor: 8.401

3.  NLRP3 inflammasome: common nexus between depression and cardiovascular diseases.

Authors:  Elísabet Alcocer-Gómez; Mario D Cordero
Journal:  Nat Rev Cardiol       Date:  2017-01-05       Impact factor: 32.419

Review 4.  Diagnostic and Therapeutic Properties of Exosomes in Cardiac Fibrosis.

Authors:  Jiwen Fan; Meng Ren; Yuquan He
Journal:  Front Cell Dev Biol       Date:  2022-07-04

5.  Inhibiting Microglia-Derived NLRP3 Alleviates Subependymal Edema and Cognitive Dysfunction in Posthemorrhagic Hydrocephalus after Intracerebral Hemorrhage via AMPK/Beclin-1 Pathway.

Authors:  Zhaoqi Zhang; Peiwen Guo; Suna Huang; Zhengcai Jia; Tunan Chen; Xin Liu; Hua Feng; Yujie Chen
Journal:  Oxid Med Cell Longev       Date:  2022-05-17       Impact factor: 7.310

6.  Protective Role of Autophagy in Nlrp3 Inflammasome Activation and Medial Thickening of Mouse Coronary Arteries.

Authors:  Xinxu Yuan; Owais M Bhat; Nan Meng; Hannah Lohner; Pin-Lan Li
Journal:  Am J Pathol       Date:  2018-09-29       Impact factor: 4.307

7.  Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.

Authors:  Jun Lu; Liwei Xu; Zifeng Zeng; Chuqing Xue; Jiale Li; Xiong Chen; Pengyu Zhou; Shaoyan Lin; Yuhui Liao; Xianjin Du; Ronghua Yang; Shaoyi Zheng
Journal:  Front Cell Dev Biol       Date:  2021-08-31

Review 8.  Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation.

Authors:  Gaia Favero; Lorenzo Franceschetti; Francesca Bonomini; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Int J Endocrinol       Date:  2017-10-01       Impact factor: 3.257

9.  Inhibition of the NLRP3/IL-1β axis protects against sepsis-induced cardiomyopathy.

Authors:  Katharina Busch; Melanie Kny; Nora Huang; Tilman E Klassert; Magdalena Stock; Alexander Hahn; Sebastian Graeger; Mihail Todiras; Sibylle Schmidt; Bishwas Chamling; Michael Willenbrock; Stefan Groß; Doreen Biedenweg; Arnd Heuser; Claus Scheidereit; Christian Butter; Stephan B Felix; Oliver Otto; Friedrich C Luft; Hortense Slevogt; Jens Fielitz
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-09-02       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.